sensitivity testing Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Helsinki University Central Hospital (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadleukemia

I am/have/hadgraft versus host disease

I am/have/hadforced expiratory volume

I am/have/hadacute promyelocytic leukemia

I am/have/hadcardiac disorder

I am/have/hadangina

I am/have/hadinduction chemotherapy

I am/have/hadrefractory aml

I am/have/hadwhite blood cell count

I am/have/hadneoadjuvant therapy

I am/have/hadcancer

I am/have/hadheart failure

I am/have/hadstable angina

I am/have/hadsecondary acute myeloid leukemia

I am/have/hadremission

I am/have/hadhepatitis

I am/have/hadHIV Infection

I am/have/hadchronic stable angina

I am/have/hadheart disease

I am/have/hadallogeneic transplantation

added new label for I am/have/had

more

I am looking for

I am looking forclofarabine

I am looking foranthracyclines

I am looking forcarbon monoxide

I am looking forhydroxyurea

I am looking forazacitidine

I am looking forcytarabine

I am looking forvenetoclax

I am looking formitoxantrone

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Hematology
Recruiting

Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening

This study will characterize the usability of ex vivo drug sensitivity testing for patient selection for selecting the responsive patients for venetoclax therapy. The exploratory study will aim to find novel combinations for overcoming resistance as well as finding/validating biomarkers for both sensitivity and resistance.

graft versus host disease

acute promyelocytic leukemia

hydroxyurea

azacitidine

angina

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.